smartpill胃肠道(gi)监测系统是由smartpill公司(buffalo, ny, usa)研发的，已经获得了美国食品药品管理局(fda)的许可，给予该公司在美国销售使用该套系统和smartpill ph.p胶囊的授权。
ingestible capsule evaluates patients for gastroparesis
a wireless, ingestible medical device, about the size of a large vitamin pill, will aid in the identification of slow gastric emptying, or gastroparesis, which has been underdiagnosed in patients for years. gastroparesis is a condition that affects a wide range of patients, including up to an estimated 50% of diabetics and those suffering from parkinson’s disease.
the smartpill gastrointestinal (gi) monitoring system developed by smartpill corp. (buffalo, ny, usa) has been cleared by the u.s. food and drug administration (fda), granting the company authorization for the sale and use of the system and the smartpill ph.p capsule in the united states.